ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Cardiff Oncology (CRDF) Technical (Analysis) Reports Cardiff Oncology ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Cardiff Oncology (CRDF)

Technical Analysis Report for NASDAQ stock CRDF Cardiff Oncology. Dated: 04 Dec 2025 Updated Daily. Stock trades in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock CRDF Cardiff Oncology then click here. or read Experts views on Cardiff Oncology or Forecast & share price targets of Cardiff Oncology

Cardiff Oncology Opened at 2.15 and Closed at: 2.17, which is 1.84% of previous session's close. It moved within a range of 2.10 and 2.20
The session was a Bullish session with an average volume of 363305, which is -130.55% of previous session's volumes.

  • Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.

Support for tomorrow is 2.14 and resistance for tomorrow is 2.24
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 2.11, 2.06 resistance for tomorrow's hourly charts is 2.21, 2.26

10 Day SMA for Cardiff Oncology (CRDF) is 2.13 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Cardiff Oncology (CRDF) is 2.14 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Cardiff Oncology (CRDF) is 2.19 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 2.39 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Cardiff Oncology is 2.87 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Cardiff Oncology is at 2.14 and 200 DMA is at 2.87, while 50 DMA and 100 DMA are at 2.19 and 2.39 respectively

Cardiff Oncology (CRDF) moving average of 20 SMA is at 2.14 and 20 EMA is at 2.15

Date Closing Price 20 SMA 20 EMA
04 Thu Dec 2.17 2.14 2.15
03 Wed Dec 2.13 2.15 2.15
02 Tue Dec 2.04 2.15 2.15
01 Mon Dec 2.17 2.17 2.16
28 Fri Nov 2.28 2.18 2.16
26 Wed Nov 2.34 2.18 2.15

Cardiff Oncology (CRDF) moving average of 50 SMA is at 2.19 and 50 EMA is at 2.23

Date Closing Price 50 SMA 50 EMA
04 Thu Dec 2.17 2.19 2.23
03 Wed Dec 2.13 2.19 2.23
02 Tue Dec 2.04 2.19 2.23
01 Mon Dec 2.17 2.19 2.24
28 Fri Nov 2.28 2.19 2.24
26 Wed Nov 2.34 2.19 2.24

Cardiff Oncology (CRDF) moving average of 100 SMA is at 2.39 and 100 EMA is at 2.38

Date Closing Price 100 SMA 100 EMA
04 Thu Dec 2.17 2.39 2.38
03 Wed Dec 2.13 2.41 2.38
02 Tue Dec 2.04 2.43 2.38
01 Mon Dec 2.17 2.45 2.39
28 Fri Nov 2.28 2.47 2.39
26 Wed Nov 2.34 2.49 2.39

Cardiff Oncology (CRDF) moving average of 200 SMA is at 2.87 and 200 EMA is at 2.62

Date Closing Price 200 SMA 200 EMA
04 Thu Dec 2.17 2.87 2.62
03 Wed Dec 2.13 2.89 2.62
02 Tue Dec 2.04 2.9 2.62
01 Mon Dec 2.17 2.91 2.63
28 Fri Nov 2.28 2.92 2.63
26 Wed Nov 2.34 2.93 2.63

Cardiff Oncology Technical analysis of indicators

Price action analysis of Cardiff Oncology (CRDF) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Cardiff Oncology stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Cardiff Oncology in short term but the buy signal is initial and weak.

Cardiff Oncology Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up

CCI has generated a buy signal for Cardiff Oncology in short term and BUY signal is strong.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Cardiff Oncology is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.12 and Cardiff Oncology CRDF stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Cardiff Oncology CRDF stock. Volume based technical analysis of Cardiff Oncology CRDF stock is negative.

Cardiff Oncology Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Cardiff Oncology indicators chart

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock CRDF Cardiff Oncology These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And CRDF Experts View which covers a lot of information including buying and selling signals

CRDF future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Cardiff Oncology or View Candle Stick Charts here

Chart Cardiff Oncology (CRDF) Technical (Analysis) Reports Cardiff Oncology [

Videos related to: Cardiff Oncology (CRDF) Technical (Analysis) Reports Cardiff Oncology ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Cardiff Oncology (CRDF) Technical (Analysis) Reports Cardiff Oncology [

 

Back to top